The Patent Finder

Realta Holdings, LLC

14 patents currently held · Updated Nov 19, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Jul 2028
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 1, 2027
    The maintenance fee for PIC1 Inhibition of Myeloperoxidase Oxidative Activity in an Animal Model (US 11,712,462) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
  • 1 fee due Mar 17, 2027
    The maintenance fee for Peptide Compounds to Regulate the Complement System (US 10,414,799) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.
  • 1 fee due May 14, 2027
    The maintenance fee for Synthetic Peptide Compounds and Methods of Use (US 11,814,414) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,241,843Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
In force
 · USPTO record
In forceUSPTO record
US 8,906,845Peptide Compounds to Regulate the Complement System
In force
 · High confidence
In forceHigh confidence
US 9,422,337Peptide Compounds to Regulate the Complement System
In force
 · High confidence
In forceHigh confidence
US 9,914,753Peptide Compounds to Regulate the Complement System
In force
 · High confidence
In forceHigh confidence
US 10,005,818Derivative peptide compounds and methods of use
In force
 · USPTO record
In forceUSPTO record
US 10,414,799Peptide Compounds to Regulate the Complement System
In force
 · High confidence
In forceHigh confidence
US 10,844,093Peptide Compounds to Regulate the Complement System
In force
 · High confidence
In forceHigh confidence
US 10,947,279Synthetic Peptide Compounds and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 11,814,414Synthetic Peptide Compounds and Methods of Use
In force
 · Medium confidence
In forceMedium confidence
US 10,933,116Synthetic Peptide Compounds and Methods of Use
In force
 · High confidence
In forceHigh confidence
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
Also on record, not counted in the 14: 1 patent in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

7 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited